Hideaki Mizuno

Summary

Affiliation: Chugai Pharmaceutical Co., Ltd.
Location: Kamakura, Japan
URL: http://researchmap.jp/mizuno/?lang=english

Publications

  1. ncbi ORI-GENE: gene classification based on the evolutionary tree
    H Mizuno
    Institute of Biological Sciences, University of Tsukuba, 1 1 1 Ten nodai, Tsukuba, Ibaraki 305 8572, Japan
    Bioinformatics 17:167-73. 2001
  2. ncbi Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway
    William A Freed-Pastor
    Department of Biological Sciences, Columbia University, New York, NY 10027, USA
    Cell 148:244-58. 2012

Collaborators

  • William A Freed-Pastor
  • Mina J Bissell
  • Bin Tian
  • Carol Prives
  • Anita Langerød
  • Alla Polotskaia
  • Anne Lise Børresen-Dale
  • Xi Zhao
  • Jose M Silva
  • Wencheng Li
  • Sung Hwan Moon
  • Arnold J Levine
  • Agustin Chicas
  • Anthony Barsotti
  • Timothy F Osborne
  • Jill Bargonetti
  • Scott W Lowe
  • Ruth Rodríguez-Barrueco

Detail Information

Publications2

  1. ncbi ORI-GENE: gene classification based on the evolutionary tree
    H Mizuno
    Institute of Biological Sciences, University of Tsukuba, 1 1 1 Ten nodai, Tsukuba, Ibaraki 305 8572, Japan
    Bioinformatics 17:167-73. 2001
    ..Therefore, new methods and tools for extracting more biological information from homology searches would be advantageous...
  2. ncbi Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway
    William A Freed-Pastor
    Department of Biological Sciences, Columbia University, New York, NY 10027, USA
    Cell 148:244-58. 2012
    ..Finally, p53 mutation correlates with highly expressed sterol biosynthesis genes in human breast tumors. These findings implicate the mevalonate pathway as a therapeutic target for tumors bearing mutations in p53...